Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment

Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children

(2022) Amy S. Shah et al.   Annual Review of Medicine

Endocrine Follow-Up During Post-Acute COVID-19: Practical Recommendations Based On Available Clinical Evidence

(2022) Rimesh Pal et al.   Endocrine Practice

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies

(2022) Jelena Vekic et al.   Metabolites

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus

(2022) Margarita Ortiz-Martínez et al.   Current Diabetes Reports

COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes

(2022) Banafsheh Bigdelou et al.   Frontiers in Immunology

The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction

(2022) Ali A Rizvi et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Uptake of guideline-recommended postpartum diabetes screening among diverse women with gestational diabetes: associations with patient factors in an integrated health system in the USA

(2022) Susan D Brown et al.   BMJ Open Diabetes Research & Care

Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome

(2021) Rosaria V. Giglio et al.   CURRENT PHARMACEUTICAL DESIGN

Unraveling the role of oxidative stress and lipid status parameters in the onset of preeclampsia

(2021) Petar Cabunac et al.   HYPERTENSION IN PREGNANCY

New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?

(2021) Djordje S. Popovic et al.   Diabetes Therapy

Factors associated with oxidative stress status in pediatric patients with type 1 diabetes mellitus

(2020) Dragana Kacarevic et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management

(2020) Anca Pantea Stoian et al.   Metabolic Syndrome and Related Disorders

Glycemic variability: adverse clinical outcomes and how to improve it?

(2020) Zheng Zhou et al.   Cardiovascular Diabetology

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

(2018) Manfredi Rizzo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Metabolic disorders during pregnancy and postpartum cardiometabolic risk

(2018) Angelo Maria Patti et al.   Endocrine Connections

Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease

(2018) Milica Miljkovic et al.   CLINICAL BIOCHEMISTRY

Pharmacotherapy for gestational diabetes

(2018) Angelo Maria Patti et al.   EXPERT OPINION ON PHARMACOTHERAPY

Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control

(2018) Dragana Bojanin et al.   ATHEROSCLEROSIS

Obesity and dyslipidemia

(2018) Jelena Vekic et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Hemostasis, endothelial stress, inflammation, and the metabolic syndrome

(2017) Gerald Grandl et al.   Seminars in Immunopathology

Pathophysiology of diabetic dyslipidaemia: where are we?

(2015) Bruno Vergès   DIABETOLOGIA

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis

(2009) Manfredi Rizzo et al.   ATHEROSCLEROSIS